Theratechnologies (Theratechnologies) Gross Margin % : 67.48% (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Theratechnologies's Gross Profit for the three months ended in Feb. 2024 was $10.96 Mil. Theratechnologies's Revenue for the three months ended in Feb. 2024 was $16.25 Mil. Therefore, Theratechnologies's Gross Margin % for the quarter that ended in Feb. 2024 was 67.48%.

The historical rank and industry rank for Theratechnologies's Gross Margin % or its related term are showing as below:

THTX' s Gross Margin % Range Over the Past 10 Years
Min: 58.75 Med: 68.92 Max: 86.61
Current: 74.12

During the past 13 years, the highest Gross Margin % of Theratechnologies was 86.61%. The lowest was 58.75%. And the median was 68.92%.

THTX's Gross Margin % is ranked better than
67.47% of 750 companies
in the Biotechnology industry
Industry Median: 60.53 vs THTX: 74.12

Theratechnologies had a gross margin of 67.48% for the quarter that ended in Feb. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Theratechnologies was 2.60% per year.

Theratechnologies Gross Margin % Historical Data

The historical data trend for Theratechnologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Gross Margin % Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Gross Margin %

Get a 7-Day Free Trial

58.75

59.27

66.69

67.17

75.99

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Gross Margin %	Get a 7-Day Free Trial															76.43	72.03	76.18	78.40	67.48

Competitive Comparison of Theratechnologies's Gross Margin %

For the Biotechnology subindustry, Theratechnologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theratechnologies's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Gross Margin % falls into.

Theratechnologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Theratechnologies's Gross Margin for the fiscal year that ended in Nov. 2023 is calculated as

Gross Margin % (A: Nov. 2023 )	=	Gross Profit (A: Nov. 2023 )	/	Revenue (A: Nov. 2023 )
	=	62.1	/	81.764
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(81.764 - 19.635)	/	81.764
	=	75.99 %

Theratechnologies's Gross Margin for the quarter that ended in Feb. 2024 is calculated as

Gross Margin % (Q: Feb. 2024 )	=	Gross Profit (Q: Feb. 2024 )	/	Revenue (Q: Feb. 2024 )
	=	11	/	16.247
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(16.247 - 5.284)	/	16.247
	=	67.48 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Theratechnologies (NAS:THTX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Theratechnologies had a gross margin of 67.48% for the quarter that ended in Feb. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Theratechnologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.